Sanofi India share news, announcements and annual reports
NSE: SANOFIBSE: 500674Pharmaceuticals & BiotechnologySmall Cap
Sanofi India Limited · Formerly Aventis Pharma · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Oct 1984 on BSE, May 2003 on NSE
Last close ₹3,349.80up ₹145.70 (4.55%)BSE ₹3,347.75
Share price at the NSE close on 2 Nov 2026. Previous close ₹3,204.10.
2 Nov: open ₹3,250.00, high ₹3,359.00, low ₹3,220.00
52-week range of traded prices to 2 Nov 2026
₹2,758.20Low, 23 Oct 2026₹4,832.00High, 3 Nov 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹7,715 Cr614th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 21.17
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 9.34
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 3.67%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 45.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 57.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Jun 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 51,31944.6% delivered
Sanofi India board meetings
108 filed, newest first. Page 3 of 3.
Apr 2008
11 Apr · Board meeting
Meeting on 23 Apr 2008: “Unaudited Financial Results for the qtr ended March 31, 2008”
Feb 2008
8 Feb · Board meeting
For approving the audited Accounts for the year ended December 31, 2007 and also to consider recommendation of Final Dividend for the said financial year.
Oct 2007
19 Oct · Board meeting
Meeting on 30 Oct 2007: “Unaudited Financial Results for the Qtr ended Sept 30, 2007”
Jul 2007
10 Jul · Board meeting
For :- (a) Approving the Unaudited Financial Results for the quarter and half year ended June 30, 2007; and (b) Considering the question of declaring an Interim Dividend for the current financial year ending on December 31, 2007.
Apr 2007
9 Apr · Board meeting
Meeting on 16 Apr 2007: “Unaudited Financial Results for the Qtr ended March 31, 2007”
Mar 2007
26 Mar · Board meeting
Board of Directors, at their meeting held on March 26, 2007, has not recommended any Final Dividend for the year ended December 31, 2006 in view of the earlier declarations by the Board of Directors of the (a) First Interim Dividend of Rs. 3.50 per equity share of Rs. 10 which was paid in August 2006 and (b) Second Interim Dividend of Rs. 28.50 per equity share of Rs. 10 (inclusive of a Special One-time Golden Jubilee Dividend of Rs. 16.00 per equity share of Rs. 10), which was declared on March 16, 2007 with the Record Date being March 24, 2007.16 Mar · Board meeting
For approving the audited Accounts for the year ended December 31, 2006 and also to consider recommendation of Final Dividend for the said financial year.9 Mar · Board meeting
For considering the question of declaring a Second Interim Dividend for the financial year ended December 31, 2006. In case the said Interim Dividend is declared by the Board at its aforesaid Meeting, the Record Date for the purpose of payment of such second Interim Dividend will be March 24, 2007.